nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—ABAT—GABA synthesis, release, reuptake and degradation—SLC6A11—melanoma	0.0303	0.0797	CbGpPWpGaD
Vigabatrin—GABBR1—GPCRs, Class C Metabotropic glutamate, pheromone—GRM3—melanoma	0.0265	0.0696	CbGpPWpGaD
Vigabatrin—GABBR1—GPCRs, Class C Metabotropic glutamate, pheromone—GRM1—melanoma	0.023	0.0604	CbGpPWpGaD
Vigabatrin—GABBR1—Class C/3 (Metabotropic glutamate/pheromone receptors)—TAS2R60—melanoma	0.02	0.0524	CbGpPWpGaD
Vigabatrin—ABAT—Neurotransmitter Release Cycle—SLC6A11—melanoma	0.0161	0.0422	CbGpPWpGaD
Vigabatrin—SLC36A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.0151	0.0397	CbGpPWpGaD
Vigabatrin—SLC36A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.0146	0.0382	CbGpPWpGaD
Vigabatrin—GABBR1—Class C/3 (Metabotropic glutamate/pheromone receptors)—GRM3—melanoma	0.0121	0.0318	CbGpPWpGaD
Vigabatrin—GABBR1—Class C/3 (Metabotropic glutamate/pheromone receptors)—GRM1—melanoma	0.0105	0.0275	CbGpPWpGaD
Vigabatrin—SLC36A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.0089	0.0234	CbGpPWpGaD
Vigabatrin—SLC36A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.00857	0.0225	CbGpPWpGaD
Vigabatrin—SLC36A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.00604	0.0159	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—TAS2R60—melanoma	0.00484	0.0127	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00462	0.0121	CbGpPWpGaD
Vigabatrin—GABBR1—hair follicle—melanoma	0.00437	0.367	CbGeAlD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.00398	0.0105	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00392	0.0103	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCB5—melanoma	0.00385	0.0101	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.00383	0.0101	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCL1—melanoma	0.00367	0.00964	CbGpPWpGaD
Vigabatrin—SLC36A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.00356	0.00935	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—SLC6A11—melanoma	0.00354	0.00929	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.00348	0.00914	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—melanoma	0.00319	0.00838	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—SLC6A11—melanoma	0.00301	0.0079	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—GRM3—melanoma	0.00293	0.0077	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—TAS2R60—melanoma	0.00293	0.0077	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00282	0.00741	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCR1—melanoma	0.00269	0.00707	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ARL2—melanoma	0.00267	0.00701	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CCR7—melanoma	0.00254	0.00668	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—GRIN2A—melanoma	0.0024	0.0063	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL1—melanoma	0.00222	0.00583	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—GRIN2A—melanoma	0.00216	0.00567	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCR2—melanoma	0.00211	0.00553	CbGpPWpGaD
Vigabatrin—Respiratory failure—Docetaxel—melanoma	0.00209	0.00344	CcSEcCtD
Vigabatrin—Pneumonia—Bleomycin—melanoma	0.00206	0.00339	CcSEcCtD
Vigabatrin—Pulmonary embolism—Docetaxel—melanoma	0.00205	0.00338	CcSEcCtD
Vigabatrin—Breast disorder—Temozolomide—melanoma	0.00203	0.00334	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.00202	0.00531	CbGpPWpGaD
Vigabatrin—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00202	0.00332	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00196	0.00323	CcSEcCtD
Vigabatrin—Candida infection—Docetaxel—melanoma	0.00196	0.00323	CcSEcCtD
Vigabatrin—Abdominal distension—Temozolomide—melanoma	0.00195	0.00321	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00195	0.00511	CbGpPWpGaD
Vigabatrin—Pneumonia—Dactinomycin—melanoma	0.00192	0.00316	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00189	0.00312	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—F2RL1—melanoma	0.00189	0.00496	CbGpPWpGaD
Vigabatrin—Oesophagitis—Docetaxel—melanoma	0.00188	0.00309	CcSEcCtD
Vigabatrin—Decreased appetite—Vemurafenib—melanoma	0.00187	0.00309	CcSEcCtD
Vigabatrin—Bronchitis—Temozolomide—melanoma	0.00186	0.00307	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Vemurafenib—melanoma	0.00186	0.00307	CcSEcCtD
Vigabatrin—Fatigue—Vemurafenib—melanoma	0.00186	0.00306	CcSEcCtD
Vigabatrin—Constipation—Vemurafenib—melanoma	0.00184	0.00304	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—GRIN2A—melanoma	0.00184	0.00482	CbGpPWpGaD
Vigabatrin—Hypoaesthesia—Bleomycin—melanoma	0.00183	0.00301	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Temozolomide—melanoma	0.0018	0.00297	CcSEcCtD
Vigabatrin—Pneumonia—Carmustine—melanoma	0.0018	0.00296	CcSEcCtD
Vigabatrin—Erectile dysfunction—Temozolomide—melanoma	0.00178	0.00294	CcSEcCtD
Vigabatrin—Depression—Carmustine—melanoma	0.00178	0.00294	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—GRM3—melanoma	0.00178	0.00466	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00177	0.00464	CbGpPWpGaD
Vigabatrin—Weight increased—Temozolomide—melanoma	0.00176	0.0029	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Carmustine—melanoma	0.00175	0.00289	CcSEcCtD
Vigabatrin—Urinary tract infection—Carmustine—melanoma	0.00174	0.00286	CcSEcCtD
Vigabatrin—Pneumonia—Temozolomide—melanoma	0.00174	0.00286	CcSEcCtD
Vigabatrin—Infestation NOS—Temozolomide—melanoma	0.00173	0.00285	CcSEcCtD
Vigabatrin—Infestation—Temozolomide—melanoma	0.00173	0.00285	CcSEcCtD
Vigabatrin—Depression—Temozolomide—melanoma	0.00172	0.00284	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00171	0.00282	CcSEcCtD
Vigabatrin—Body temperature increased—Vemurafenib—melanoma	0.0017	0.00281	CcSEcCtD
Vigabatrin—ABAT—eye—melanoma	0.0017	0.143	CbGeAlD
Vigabatrin—Neuropathy peripheral—Temozolomide—melanoma	0.00169	0.00279	CcSEcCtD
Vigabatrin—ABAT—retina—melanoma	0.00169	0.142	CbGeAlD
Vigabatrin—GABBR1—GPCR ligand binding—KISS1—melanoma	0.00168	0.00442	CbGpPWpGaD
Vigabatrin—Urinary tract infection—Temozolomide—melanoma	0.00168	0.00277	CcSEcCtD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.00168	0.0044	CbGpPWpGaD
Vigabatrin—Deafness—Docetaxel—melanoma	0.00167	0.00274	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—TAS2R60—melanoma	0.00166	0.00435	CbGpPWpGaD
Vigabatrin—Hepatobiliary disease—Temozolomide—melanoma	0.00163	0.00269	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CXCR1—melanoma	0.00163	0.00428	CbGpPWpGaD
Vigabatrin—Erythema multiforme—Dactinomycin—melanoma	0.00162	0.00267	CcSEcCtD
Vigabatrin—Sinusitis—Temozolomide—melanoma	0.00162	0.00267	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—MC1R—melanoma	0.00161	0.00422	CbGpPWpGaD
Vigabatrin—Hallucination—Carmustine—melanoma	0.0016	0.00263	CcSEcCtD
Vigabatrin—Hypoaesthesia—Carmustine—melanoma	0.0016	0.00263	CcSEcCtD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.00159	0.00418	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Vemurafenib—melanoma	0.00159	0.00262	CcSEcCtD
Vigabatrin—Oedema peripheral—Carmustine—melanoma	0.00158	0.0026	CcSEcCtD
Vigabatrin—Connective tissue disorder—Carmustine—melanoma	0.00158	0.0026	CcSEcCtD
Vigabatrin—Asthenia—Vemurafenib—melanoma	0.00155	0.00255	CcSEcCtD
Vigabatrin—Visual impairment—Carmustine—melanoma	0.00155	0.00255	CcSEcCtD
Vigabatrin—Hypoaesthesia—Temozolomide—melanoma	0.00154	0.00254	CcSEcCtD
Vigabatrin—Hallucination—Temozolomide—melanoma	0.00154	0.00254	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCR4—melanoma	0.00154	0.00405	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GRM1—melanoma	0.00154	0.00404	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCR7—melanoma	0.00154	0.00404	CbGpPWpGaD
Vigabatrin—Oedema peripheral—Temozolomide—melanoma	0.00153	0.00252	CcSEcCtD
Vigabatrin—Pruritus—Vemurafenib—melanoma	0.00153	0.00251	CcSEcCtD
Vigabatrin—Connective tissue disorder—Temozolomide—melanoma	0.00152	0.00251	CcSEcCtD
Vigabatrin—Lethargy—Docetaxel—melanoma	0.00152	0.00251	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—TAS2R60—melanoma	0.0015	0.00395	CbGpPWpGaD
Vigabatrin—Eye disorder—Carmustine—melanoma	0.0015	0.00247	CcSEcCtD
Vigabatrin—Visual impairment—Temozolomide—melanoma	0.00149	0.00246	CcSEcCtD
Vigabatrin—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00149	0.00246	CcSEcCtD
Vigabatrin—Pain in extremity—Docetaxel—melanoma	0.00149	0.00246	CcSEcCtD
Vigabatrin—Ill-defined disorder—Bleomycin—melanoma	0.00149	0.00245	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—PRKCA—melanoma	0.00148	0.00389	CbGpPWpGaD
Vigabatrin—Anaemia—Bleomycin—melanoma	0.00148	0.00244	CcSEcCtD
Vigabatrin—Diarrhoea—Vemurafenib—melanoma	0.00148	0.00243	CcSEcCtD
Vigabatrin—Erythema multiforme—Temozolomide—melanoma	0.00147	0.00241	CcSEcCtD
Vigabatrin—Eye disorder—Temozolomide—melanoma	0.00145	0.00239	CcSEcCtD
Vigabatrin—Tinnitus—Temozolomide—melanoma	0.00145	0.00238	CcSEcCtD
Vigabatrin—Malaise—Bleomycin—melanoma	0.00144	0.00238	CcSEcCtD
Vigabatrin—Dizziness—Vemurafenib—melanoma	0.00143	0.00235	CcSEcCtD
Vigabatrin—Mental disorder—Carmustine—melanoma	0.00141	0.00232	CcSEcCtD
Vigabatrin—Ataxia—Docetaxel—melanoma	0.0014	0.00231	CcSEcCtD
Vigabatrin—Malnutrition—Carmustine—melanoma	0.0014	0.0023	CcSEcCtD
Vigabatrin—Cough—Bleomycin—melanoma	0.0014	0.0023	CcSEcCtD
Vigabatrin—Ill-defined disorder—Dactinomycin—melanoma	0.00139	0.00228	CcSEcCtD
Vigabatrin—Anaemia—Dactinomycin—melanoma	0.00138	0.00227	CcSEcCtD
Vigabatrin—Vomiting—Vemurafenib—melanoma	0.00137	0.00226	CcSEcCtD
Vigabatrin—Chest pain—Bleomycin—melanoma	0.00136	0.00224	CcSEcCtD
Vigabatrin—Myalgia—Bleomycin—melanoma	0.00136	0.00224	CcSEcCtD
Vigabatrin—Abdominal pain upper—Docetaxel—melanoma	0.00136	0.00224	CcSEcCtD
Vigabatrin—Rash—Vemurafenib—melanoma	0.00136	0.00224	CcSEcCtD
Vigabatrin—Mental disorder—Temozolomide—melanoma	0.00136	0.00224	CcSEcCtD
Vigabatrin—Dermatitis—Vemurafenib—melanoma	0.00136	0.00224	CcSEcCtD
Vigabatrin—Back pain—Carmustine—melanoma	0.00135	0.00223	CcSEcCtD
Vigabatrin—Headache—Vemurafenib—melanoma	0.00135	0.00222	CcSEcCtD
Vigabatrin—Malnutrition—Temozolomide—melanoma	0.00135	0.00222	CcSEcCtD
Vigabatrin—Breast disorder—Docetaxel—melanoma	0.00135	0.00222	CcSEcCtD
Vigabatrin—Discomfort—Bleomycin—melanoma	0.00135	0.00222	CcSEcCtD
Vigabatrin—Malaise—Dactinomycin—melanoma	0.00135	0.00222	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00134	0.00221	CcSEcCtD
Vigabatrin—Nasopharyngitis—Docetaxel—melanoma	0.00133	0.0022	CcSEcCtD
Vigabatrin—Confusional state—Bleomycin—melanoma	0.00132	0.00217	CcSEcCtD
Vigabatrin—Vision blurred—Carmustine—melanoma	0.00132	0.00217	CcSEcCtD
Vigabatrin—Tremor—Carmustine—melanoma	0.00131	0.00216	CcSEcCtD
Vigabatrin—Oedema—Bleomycin—melanoma	0.00131	0.00215	CcSEcCtD
Vigabatrin—Back pain—Temozolomide—melanoma	0.00131	0.00215	CcSEcCtD
Vigabatrin—Infection—Bleomycin—melanoma	0.0013	0.00214	CcSEcCtD
Vigabatrin—Anaemia—Carmustine—melanoma	0.00129	0.00213	CcSEcCtD
Vigabatrin—Agitation—Carmustine—melanoma	0.00128	0.00211	CcSEcCtD
Vigabatrin—Nausea—Vemurafenib—melanoma	0.00128	0.00211	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CXCR2—melanoma	0.00128	0.00335	CbGpPWpGaD
Vigabatrin—Vision blurred—Temozolomide—melanoma	0.00127	0.0021	CcSEcCtD
Vigabatrin—Myalgia—Dactinomycin—melanoma	0.00127	0.00209	CcSEcCtD
Vigabatrin—Tremor—Temozolomide—melanoma	0.00127	0.00208	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—PRKCA—melanoma	0.00126	0.00331	CbGpPWpGaD
Vigabatrin—Discomfort—Dactinomycin—melanoma	0.00126	0.00207	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL1—melanoma	0.00126	0.0033	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PLCB4—melanoma	0.00126	0.0033	CbGpPWpGaD
Vigabatrin—Ill-defined disorder—Temozolomide—melanoma	0.00125	0.00206	CcSEcCtD
Vigabatrin—Anaemia—Temozolomide—melanoma	0.00125	0.00206	CcSEcCtD
Vigabatrin—Agitation—Temozolomide—melanoma	0.00124	0.00204	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—WNT5A—melanoma	0.00124	0.00325	CbGpPWpGaD
Vigabatrin—Angioedema—Temozolomide—melanoma	0.00123	0.00203	CcSEcCtD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	0.00123	0.00324	CbGpPWpGaD
Vigabatrin—Oedema—Dactinomycin—melanoma	0.00122	0.00201	CcSEcCtD
Vigabatrin—Malaise—Temozolomide—melanoma	0.00122	0.00201	CcSEcCtD
Vigabatrin—Vertigo—Temozolomide—melanoma	0.00121	0.002	CcSEcCtD
Vigabatrin—Convulsion—Carmustine—melanoma	0.00121	0.00199	CcSEcCtD
Vigabatrin—Infection—Dactinomycin—melanoma	0.00121	0.00199	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Bleomycin—melanoma	0.00119	0.00196	CcSEcCtD
Vigabatrin—Myalgia—Carmustine—melanoma	0.00119	0.00196	CcSEcCtD
Vigabatrin—Chest pain—Carmustine—melanoma	0.00119	0.00196	CcSEcCtD
Vigabatrin—Anxiety—Carmustine—melanoma	0.00119	0.00195	CcSEcCtD
Vigabatrin—Cough—Temozolomide—melanoma	0.00118	0.00194	CcSEcCtD
Vigabatrin—Paraesthesia—Bleomycin—melanoma	0.00117	0.00193	CcSEcCtD
Vigabatrin—Weight increased—Docetaxel—melanoma	0.00117	0.00193	CcSEcCtD
Vigabatrin—Convulsion—Temozolomide—melanoma	0.00117	0.00193	CcSEcCtD
Vigabatrin—Pneumonia—Docetaxel—melanoma	0.00116	0.0019	CcSEcCtD
Vigabatrin—Confusional state—Carmustine—melanoma	0.00115	0.00189	CcSEcCtD
Vigabatrin—Myalgia—Temozolomide—melanoma	0.00115	0.00189	CcSEcCtD
Vigabatrin—Arthralgia—Temozolomide—melanoma	0.00115	0.00189	CcSEcCtD
Vigabatrin—Infestation NOS—Docetaxel—melanoma	0.00115	0.00189	CcSEcCtD
Vigabatrin—Infestation—Docetaxel—melanoma	0.00115	0.00189	CcSEcCtD
Vigabatrin—Anxiety—Temozolomide—melanoma	0.00115	0.00189	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00114	0.00188	CcSEcCtD
Vigabatrin—Oedema—Carmustine—melanoma	0.00114	0.00188	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL1—melanoma	0.00114	0.00299	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PLCB4—melanoma	0.00114	0.00299	CbGpPWpGaD
Vigabatrin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00114	0.00188	CcSEcCtD
Vigabatrin—Discomfort—Temozolomide—melanoma	0.00114	0.00187	CcSEcCtD
Vigabatrin—Decreased appetite—Bleomycin—melanoma	0.00114	0.00187	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—PRKCA—melanoma	0.00113	0.00298	CbGpPWpGaD
Vigabatrin—Infection—Carmustine—melanoma	0.00113	0.00187	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Docetaxel—melanoma	0.00113	0.00185	CcSEcCtD
Vigabatrin—Pain—Bleomycin—melanoma	0.00112	0.00184	CcSEcCtD
Vigabatrin—Conjunctivitis—Docetaxel—melanoma	0.00112	0.00184	CcSEcCtD
Vigabatrin—Confusional state—Temozolomide—melanoma	0.00111	0.00183	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00111	0.00183	CcSEcCtD
Vigabatrin—Oedema—Temozolomide—melanoma	0.0011	0.00181	CcSEcCtD
Vigabatrin—Infection—Temozolomide—melanoma	0.00109	0.0018	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—BRAF—melanoma	0.00109	0.00286	CbGpPWpGaD
Vigabatrin—Hepatobiliary disease—Docetaxel—melanoma	0.00109	0.00179	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—F2R—melanoma	0.00108	0.00285	CbGpPWpGaD
Vigabatrin—Nervous system disorder—Temozolomide—melanoma	0.00108	0.00178	CcSEcCtD
Vigabatrin—Feeling abnormal—Bleomycin—melanoma	0.00108	0.00177	CcSEcCtD
Vigabatrin—Skin disorder—Temozolomide—melanoma	0.00107	0.00176	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—F2RL1—melanoma	0.00107	0.0028	CbGpPWpGaD
Vigabatrin—Decreased appetite—Dactinomycin—melanoma	0.00106	0.00174	CcSEcCtD
Vigabatrin—Fatigue—Dactinomycin—melanoma	0.00105	0.00173	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—EDNRB—melanoma	0.00105	0.00276	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—DRAP1—melanoma	0.00104	0.00274	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MYO7A—melanoma	0.00104	0.00274	CbGpPWpGaD
Vigabatrin—Pain—Dactinomycin—melanoma	0.00104	0.00172	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Carmustine—melanoma	0.00104	0.00171	CcSEcCtD
Vigabatrin—Urticaria—Bleomycin—melanoma	0.00104	0.00171	CcSEcCtD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	0.00103	0.00271	CbGpPWpGaD
Vigabatrin—Body temperature increased—Bleomycin—melanoma	0.00103	0.0017	CcSEcCtD
Vigabatrin—Insomnia—Carmustine—melanoma	0.00103	0.0017	CcSEcCtD
Vigabatrin—Hypoaesthesia—Docetaxel—melanoma	0.00103	0.00169	CcSEcCtD
Vigabatrin—Paraesthesia—Carmustine—melanoma	0.00102	0.00169	CcSEcCtD
Vigabatrin—Oedema peripheral—Docetaxel—melanoma	0.00102	0.00167	CcSEcCtD
Vigabatrin—Somnolence—Carmustine—melanoma	0.00101	0.00167	CcSEcCtD
Vigabatrin—Connective tissue disorder—Docetaxel—melanoma	0.00101	0.00167	CcSEcCtD
Vigabatrin—Feeling abnormal—Dactinomycin—melanoma	0.001	0.00165	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Temozolomide—melanoma	0.001	0.00165	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—GRM3—melanoma	0.001	0.00264	CbGpPWpGaD
Vigabatrin—Insomnia—Temozolomide—melanoma	0.000997	0.00164	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Dactinomycin—melanoma	0.000996	0.00164	CcSEcCtD
Vigabatrin—Visual impairment—Docetaxel—melanoma	0.000994	0.00164	CcSEcCtD
Vigabatrin—Decreased appetite—Carmustine—melanoma	0.000991	0.00163	CcSEcCtD
Vigabatrin—Paraesthesia—Temozolomide—melanoma	0.00099	0.00163	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Carmustine—melanoma	0.000985	0.00162	CcSEcCtD
Vigabatrin—Somnolence—Temozolomide—melanoma	0.00098	0.00161	CcSEcCtD
Vigabatrin—Erythema multiforme—Docetaxel—melanoma	0.000975	0.00161	CcSEcCtD
Vigabatrin—Pain—Carmustine—melanoma	0.000975	0.00161	CcSEcCtD
Vigabatrin—Constipation—Carmustine—melanoma	0.000975	0.00161	CcSEcCtD
Vigabatrin—SLC36A1—head—melanoma	0.000972	0.0816	CbGeAlD
Vigabatrin—Dyspepsia—Temozolomide—melanoma	0.00097	0.0016	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—F2RL1—melanoma	0.000969	0.00255	CbGpPWpGaD
Vigabatrin—ABAT—head—melanoma	0.000966	0.0811	CbGeAlD
Vigabatrin—GABBR1—Neuronal System—PRKCA—melanoma	0.000965	0.00253	CbGpPWpGaD
Vigabatrin—Eye disorder—Docetaxel—melanoma	0.000964	0.00159	CcSEcCtD
Vigabatrin—Body temperature increased—Dactinomycin—melanoma	0.000963	0.00159	CcSEcCtD
Vigabatrin—Abdominal pain—Dactinomycin—melanoma	0.000963	0.00159	CcSEcCtD
Vigabatrin—Hypersensitivity—Bleomycin—melanoma	0.000963	0.00158	CcSEcCtD
Vigabatrin—Decreased appetite—Temozolomide—melanoma	0.000958	0.00158	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Temozolomide—melanoma	0.000952	0.00157	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—KISS1—melanoma	0.000951	0.0025	CbGpPWpGaD
Vigabatrin—Fatigue—Temozolomide—melanoma	0.00095	0.00156	CcSEcCtD
Vigabatrin—Pain—Temozolomide—melanoma	0.000942	0.00155	CcSEcCtD
Vigabatrin—Constipation—Temozolomide—melanoma	0.000942	0.00155	CcSEcCtD
Vigabatrin—Feeling abnormal—Carmustine—melanoma	0.00094	0.00155	CcSEcCtD
Vigabatrin—Asthenia—Bleomycin—melanoma	0.000937	0.00154	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CXCR4—melanoma	0.000933	0.00245	CbGpPWpGaD
Vigabatrin—Gastrointestinal pain—Carmustine—melanoma	0.000933	0.00154	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—BRAF—melanoma	0.000927	0.00244	CbGpPWpGaD
Vigabatrin—Pruritus—Bleomycin—melanoma	0.000924	0.00152	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCR1—melanoma	0.000921	0.00242	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—MDM2—melanoma	0.000914	0.0024	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GRM3—melanoma	0.000911	0.00239	CbGpPWpGaD
Vigabatrin—Feeling abnormal—Temozolomide—melanoma	0.000908	0.0015	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—MC1R—melanoma	0.000908	0.00238	CbGpPWpGaD
Vigabatrin—Mental disorder—Docetaxel—melanoma	0.000904	0.00149	CcSEcCtD
Vigabatrin—Abdominal pain—Carmustine—melanoma	0.000902	0.00148	CcSEcCtD
Vigabatrin—Body temperature increased—Carmustine—melanoma	0.000902	0.00148	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Temozolomide—melanoma	0.000901	0.00148	CcSEcCtD
Vigabatrin—Malnutrition—Docetaxel—melanoma	0.000898	0.00148	CcSEcCtD
Vigabatrin—Hypersensitivity—Dactinomycin—melanoma	0.000898	0.00148	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—TAS2R60—melanoma	0.000889	0.00233	CbGpPWpGaD
Vigabatrin—Urticaria—Temozolomide—melanoma	0.000876	0.00144	CcSEcCtD
Vigabatrin—Asthenia—Dactinomycin—melanoma	0.000874	0.00144	CcSEcCtD
Vigabatrin—Body temperature increased—Temozolomide—melanoma	0.000871	0.00143	CcSEcCtD
Vigabatrin—Abdominal pain—Temozolomide—melanoma	0.000871	0.00143	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—GRM1—melanoma	0.00087	0.00229	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR7—melanoma	0.00087	0.00229	CbGpPWpGaD
Vigabatrin—Back pain—Docetaxel—melanoma	0.000869	0.00143	CcSEcCtD
Vigabatrin—GABBR1—lymph node—melanoma	0.000866	0.0727	CbGeAlD
Vigabatrin—GABBR1—Signaling by GPCR—KISS1—melanoma	0.000864	0.00227	CbGpPWpGaD
Vigabatrin—Muscle spasms—Docetaxel—melanoma	0.000863	0.00142	CcSEcCtD
Vigabatrin—Hypersensitivity—Carmustine—melanoma	0.00084	0.00138	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CXCR1—melanoma	0.000837	0.0022	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—BRAF—melanoma	0.000835	0.00219	CbGpPWpGaD
Vigabatrin—Diarrhoea—Dactinomycin—melanoma	0.000834	0.00137	CcSEcCtD
Vigabatrin—Vomiting—Bleomycin—melanoma	0.000831	0.00137	CcSEcCtD
Vigabatrin—Anaemia—Docetaxel—melanoma	0.00083	0.00137	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—MC1R—melanoma	0.000824	0.00216	CbGpPWpGaD
Vigabatrin—Rash—Bleomycin—melanoma	0.000824	0.00136	CcSEcCtD
Vigabatrin—Dermatitis—Bleomycin—melanoma	0.000823	0.00136	CcSEcCtD
Vigabatrin—Asthenia—Carmustine—melanoma	0.000818	0.00135	CcSEcCtD
Vigabatrin—Hypersensitivity—Temozolomide—melanoma	0.000812	0.00134	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000808	0.00212	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—RHOB—melanoma	0.000792	0.00208	CbGpPWpGaD
Vigabatrin—Asthenia—Temozolomide—melanoma	0.000791	0.0013	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CCR7—melanoma	0.00079	0.00208	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GRM1—melanoma	0.00079	0.00208	CbGpPWpGaD
Vigabatrin—Cough—Docetaxel—melanoma	0.000784	0.00129	CcSEcCtD
Vigabatrin—Diarrhoea—Carmustine—melanoma	0.00078	0.00128	CcSEcCtD
Vigabatrin—Pruritus—Temozolomide—melanoma	0.00078	0.00128	CcSEcCtD
Vigabatrin—Convulsion—Docetaxel—melanoma	0.000778	0.00128	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—MDM2—melanoma	0.000777	0.00204	CbGpPWpGaD
Vigabatrin—Nausea—Bleomycin—melanoma	0.000776	0.00128	CcSEcCtD
Vigabatrin—Vomiting—Dactinomycin—melanoma	0.000775	0.00128	CcSEcCtD
Vigabatrin—Rash—Dactinomycin—melanoma	0.000768	0.00126	CcSEcCtD
Vigabatrin—Myalgia—Docetaxel—melanoma	0.000765	0.00126	CcSEcCtD
Vigabatrin—Chest pain—Docetaxel—melanoma	0.000765	0.00126	CcSEcCtD
Vigabatrin—Arthralgia—Docetaxel—melanoma	0.000765	0.00126	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000759	0.00125	CcSEcCtD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—ALB—melanoma	0.000759	0.00199	CbGpPWpGaD
Vigabatrin—Dizziness—Carmustine—melanoma	0.000754	0.00124	CcSEcCtD
Vigabatrin—Diarrhoea—Temozolomide—melanoma	0.000754	0.00124	CcSEcCtD
Vigabatrin—Confusional state—Docetaxel—melanoma	0.000739	0.00122	CcSEcCtD
Vigabatrin—Oedema—Docetaxel—melanoma	0.000733	0.00121	CcSEcCtD
Vigabatrin—Dizziness—Temozolomide—melanoma	0.000729	0.0012	CcSEcCtD
Vigabatrin—Infection—Docetaxel—melanoma	0.000728	0.0012	CcSEcCtD
Vigabatrin—Vomiting—Carmustine—melanoma	0.000725	0.00119	CcSEcCtD
Vigabatrin—Nausea—Dactinomycin—melanoma	0.000724	0.00119	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCR2—melanoma	0.000721	0.00189	CbGpPWpGaD
Vigabatrin—Rash—Carmustine—melanoma	0.000719	0.00118	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—RHOB—melanoma	0.000719	0.00189	CbGpPWpGaD
Vigabatrin—Nervous system disorder—Docetaxel—melanoma	0.000719	0.00118	CcSEcCtD
Vigabatrin—Dermatitis—Carmustine—melanoma	0.000718	0.00118	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—EDN1—melanoma	0.000715	0.00188	CbGpPWpGaD
Vigabatrin—Headache—Carmustine—melanoma	0.000714	0.00118	CcSEcCtD
Vigabatrin—Skin disorder—Docetaxel—melanoma	0.000712	0.00117	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—BRAF—melanoma	0.00071	0.00187	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—RAC2—melanoma	0.000709	0.00186	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	0.000706	0.00186	CbGpPWpGaD
Vigabatrin—Vomiting—Temozolomide—melanoma	0.000701	0.00115	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—MDM2—melanoma	0.0007	0.00184	CbGpPWpGaD
Vigabatrin—Rash—Temozolomide—melanoma	0.000695	0.00114	CcSEcCtD
Vigabatrin—Dermatitis—Temozolomide—melanoma	0.000694	0.00114	CcSEcCtD
Vigabatrin—Headache—Temozolomide—melanoma	0.00069	0.00114	CcSEcCtD
Vigabatrin—SLC36A1—lymph node—melanoma	0.000681	0.0571	CbGeAlD
Vigabatrin—Nausea—Carmustine—melanoma	0.000677	0.00112	CcSEcCtD
Vigabatrin—ABAT—lymph node—melanoma	0.000676	0.0568	CbGeAlD
Vigabatrin—GABBR1—Signaling Pathways—PLCB4—melanoma	0.000673	0.00177	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL1—melanoma	0.000673	0.00177	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000668	0.0011	CcSEcCtD
Vigabatrin—Insomnia—Docetaxel—melanoma	0.000663	0.00109	CcSEcCtD
Vigabatrin—Paraesthesia—Docetaxel—melanoma	0.000658	0.00108	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CXCR2—melanoma	0.000655	0.00172	CbGpPWpGaD
Vigabatrin—Nausea—Temozolomide—melanoma	0.000655	0.00108	CcSEcCtD
Vigabatrin—Somnolence—Docetaxel—melanoma	0.000652	0.00107	CcSEcCtD
Vigabatrin—Dyspepsia—Docetaxel—melanoma	0.000645	0.00106	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—RAC2—melanoma	0.000644	0.00169	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCL8—melanoma	0.000638	0.00168	CbGpPWpGaD
Vigabatrin—Decreased appetite—Docetaxel—melanoma	0.000637	0.00105	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—WNT5A—melanoma	0.000634	0.00167	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TRRAP—melanoma	0.000633	0.00166	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CUL3—melanoma	0.000633	0.00166	CbGpPWpGaD
Vigabatrin—Gastrointestinal disorder—Docetaxel—melanoma	0.000633	0.00104	CcSEcCtD
Vigabatrin—Fatigue—Docetaxel—melanoma	0.000632	0.00104	CcSEcCtD
Vigabatrin—Constipation—Docetaxel—melanoma	0.000627	0.00103	CcSEcCtD
Vigabatrin—Pain—Docetaxel—melanoma	0.000627	0.00103	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—MAPK1—melanoma	0.000624	0.00164	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCB1—melanoma	0.000616	0.00162	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKR1B10—melanoma	0.000616	0.00162	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—F2R—melanoma	0.000613	0.00161	CbGpPWpGaD
Vigabatrin—Feeling abnormal—Docetaxel—melanoma	0.000604	0.000994	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Docetaxel—melanoma	0.000599	0.000987	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—MDM2—melanoma	0.000595	0.00156	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—EDNRB—melanoma	0.000594	0.00156	CbGpPWpGaD
Vigabatrin—Body temperature increased—Docetaxel—melanoma	0.000579	0.000954	CcSEcCtD
Vigabatrin—Abdominal pain—Docetaxel—melanoma	0.000579	0.000954	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—F2RL1—melanoma	0.000573	0.0015	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000567	0.00149	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GAB2—melanoma	0.000561	0.00147	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GNA11—melanoma	0.000561	0.00147	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—F2R—melanoma	0.000557	0.00146	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Docetaxel—melanoma	0.00054	0.000889	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—EDNRB—melanoma	0.000539	0.00142	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GRM3—melanoma	0.000538	0.00141	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—MAPK1—melanoma	0.000531	0.00139	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCR4—melanoma	0.000527	0.00138	CbGpPWpGaD
Vigabatrin—Asthenia—Docetaxel—melanoma	0.000526	0.000866	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—GNAQ—melanoma	0.000521	0.00137	CbGpPWpGaD
Vigabatrin—Pruritus—Docetaxel—melanoma	0.000519	0.000854	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—KISS1—melanoma	0.00051	0.00134	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GAB2—melanoma	0.000509	0.00134	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GNA11—melanoma	0.000509	0.00134	CbGpPWpGaD
Vigabatrin—Diarrhoea—Docetaxel—melanoma	0.000501	0.000826	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—HRAS—melanoma	0.000501	0.00132	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SKI—melanoma	0.000494	0.0013	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCR1—melanoma	0.000494	0.0013	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MC1R—melanoma	0.000487	0.00128	CbGpPWpGaD
Vigabatrin—Dizziness—Docetaxel—melanoma	0.000485	0.000798	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT3—melanoma	0.000481	0.00126	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCR4—melanoma	0.000479	0.00126	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—MAPK1—melanoma	0.000478	0.00126	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GNAQ—melanoma	0.000473	0.00124	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GRM1—melanoma	0.000467	0.00123	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCR7—melanoma	0.000467	0.00123	CbGpPWpGaD
Vigabatrin—Vomiting—Docetaxel—melanoma	0.000466	0.000767	CcSEcCtD
Vigabatrin—Rash—Docetaxel—melanoma	0.000462	0.000761	CcSEcCtD
Vigabatrin—Dermatitis—Docetaxel—melanoma	0.000462	0.00076	CcSEcCtD
Vigabatrin—Headache—Docetaxel—melanoma	0.000459	0.000756	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—SUFU—melanoma	0.000455	0.00119	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT3—melanoma	0.000437	0.00115	CbGpPWpGaD
Vigabatrin—Nausea—Docetaxel—melanoma	0.000435	0.000717	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—HRAS—melanoma	0.000426	0.00112	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—BCL2L11—melanoma	0.000425	0.00112	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RHOB—melanoma	0.000425	0.00112	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HDAC6—melanoma	0.000408	0.00107	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—MAPK1—melanoma	0.000407	0.00107	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—EDN1—melanoma	0.000404	0.00106	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CSF2—melanoma	0.000395	0.00104	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCR2—melanoma	0.000387	0.00102	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL8—melanoma	0.000387	0.00102	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ALB—melanoma	0.000386	0.00101	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—HRAS—melanoma	0.000384	0.00101	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RAC2—melanoma	0.00038	0.000999	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PRKCA—melanoma	0.000379	0.000995	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VEGFC—melanoma	0.000375	0.000984	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—WNT5A—melanoma	0.000375	0.000984	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—EDN1—melanoma	0.000367	0.000964	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CSF2—melanoma	0.000359	0.000942	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—RAC1—melanoma	0.000351	0.000922	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PRKCA—melanoma	0.000344	0.000903	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MAP2K2—melanoma	0.000336	0.000883	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—F2R—melanoma	0.000329	0.000864	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—HRAS—melanoma	0.000327	0.000858	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—RAC1—melanoma	0.000319	0.000837	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EDNRB—melanoma	0.000318	0.000837	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTK2B—melanoma	0.000309	0.000812	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GAB2—melanoma	0.000301	0.00079	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GNA11—melanoma	0.000301	0.00079	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FLT1—melanoma	0.000299	0.000787	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CG—melanoma	0.000297	0.000779	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FOXO4—melanoma	0.000283	0.000743	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HDAC2—melanoma	0.000283	0.000743	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCR4—melanoma	0.000283	0.000743	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GNAQ—melanoma	0.00028	0.000734	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CG—melanoma	0.000269	0.000708	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SYK—melanoma	0.000263	0.000691	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CD—melanoma	0.000261	0.000685	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NGFR—melanoma	0.000258	0.000678	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ITGAV—melanoma	0.000258	0.000678	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT3—melanoma	0.000258	0.000678	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SOCS1—melanoma	0.000239	0.000628	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MAP2K1—melanoma	0.000238	0.000626	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—S100B—melanoma	0.000238	0.000626	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CD—melanoma	0.000237	0.000622	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ERBB4—melanoma	0.000228	0.000599	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CB—melanoma	0.000227	0.000597	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CDKN2B—melanoma	0.000226	0.000593	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CD86—melanoma	0.000219	0.000574	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL8—melanoma	0.000218	0.000574	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EDN1—melanoma	0.000217	0.000569	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CSF2—melanoma	0.000212	0.000557	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FGF1—melanoma	0.000212	0.000557	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—IL2—melanoma	0.000209	0.000548	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—E2F1—melanoma	0.000207	0.000545	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CB—melanoma	0.000206	0.000542	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PDGFRA—melanoma	0.000205	0.000539	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ITGB3—melanoma	0.000203	0.000534	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PRKCA—melanoma	0.000203	0.000534	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SPP1—melanoma	0.000199	0.000523	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAP2K2—melanoma	0.000199	0.000522	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL8—melanoma	0.000198	0.000521	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL2—melanoma	0.00019	0.000498	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TERT—melanoma	0.000189	0.000496	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RAC1—melanoma	0.000188	0.000495	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HIF1A—melanoma	0.000181	0.000474	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KDR—melanoma	0.000173	0.000454	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FN1—melanoma	0.000166	0.000437	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NOTCH1—melanoma	0.000163	0.000427	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CD80—melanoma	0.000159	0.000419	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CG—melanoma	0.000159	0.000418	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KIT—melanoma	0.000159	0.000418	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APC—melanoma	0.000159	0.000418	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—NRAS—melanoma	0.000159	0.000418	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EGF—melanoma	0.000157	0.000413	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MAPK3—melanoma	0.000152	0.0004	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—BRAF—melanoma	0.00015	0.000393	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IGF1—melanoma	0.000146	0.000383	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MAPK1—melanoma	0.000145	0.000381	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—EGFR—melanoma	0.000145	0.000381	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAP2K1—melanoma	0.000141	0.00037	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CD—melanoma	0.00014	0.000367	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CA—melanoma	0.000139	0.000364	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—KRAS—melanoma	0.000137	0.00036	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FGF2—melanoma	0.000134	0.000352	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CA—melanoma	0.000126	0.000331	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MDM2—melanoma	0.000125	0.000329	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ERBB2—melanoma	0.000124	0.000325	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CB—melanoma	0.000122	0.00032	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL8—melanoma	0.000117	0.000308	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HRAS—melanoma	0.000116	0.000306	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CDKN1B—melanoma	0.000114	0.000301	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT1—melanoma	0.000113	0.000297	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CASP3—melanoma	0.000112	0.000295	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL2—melanoma	0.000112	0.000294	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL6—melanoma	0.000111	0.000293	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCND1—melanoma	0.000109	0.000287	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CTNNB1—melanoma	0.000108	0.000284	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP9—melanoma	0.000106	0.000278	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CDKN1A—melanoma	0.000106	0.000277	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTEN—melanoma	0.000105	0.000277	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NFKB1—melanoma	0.000105	0.000275	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT1—melanoma	0.000103	0.00027	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VEGFA—melanoma	9.52e-05	0.00025	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—STAT3—melanoma	9.42e-05	0.000248	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NRAS—melanoma	9.4e-05	0.000247	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAPK3—melanoma	9e-05	0.000236	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MYC—melanoma	8.76e-05	0.00023	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAPK1—melanoma	8.57e-05	0.000225	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EGFR—melanoma	8.56e-05	0.000225	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KRAS—melanoma	8.09e-05	0.000213	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CA—melanoma	7.43e-05	0.000195	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TP53—melanoma	7.19e-05	0.000189	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HRAS—melanoma	6.88e-05	0.000181	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6—melanoma	6.58e-05	0.000173	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT1—melanoma	6.07e-05	0.000159	CbGpPWpGaD
